ARCHIVES

Includes 8-page April 2002 Business & Regulatory Report.

This article is from The Cancer Letter archive.

Vol. 28 No. 18 | May 3, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

MSKCC In Outreach Agreement With Phelps

December 1, 1995

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCI Announces Designation Of Comprehensive Center

July 20, 1990